CVE-2026-84842: IBM Guardium Data Protection · Path Traversal
Affects IBM Guardium Data ProtectionSource CVE Database V5
Not known to be exploited · CVSS 8.1 High.
Data as of 26 Oct 2026, 11:07 UTC
- EPSS
- 0.3% chance of exploitation in 30 days – higher than 32% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
- CISA SSVC
- Exploitation
- No evidence of active exploitation and no public proof of concept
- Automatable
- Attackers cannot reliably automate steps 1–4 of the kill chain
- Technical impact
- Limited control over the software or limited information exposure
CISA SSVC assessment, 2026-09-29.
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:HExploitation evidence
Disclosed: evidence found.
CVE published 29 Sep 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 24 Oct 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| IBMGuardium Data Protection | Affected
| Fixed in– |
CPE configurations (2)
cpe:2.3:a:ibm:guardium_data_protection:12.2:*:*:*:*:*:*:*cpe:2.3:a:ibm:guardium_data_protection:12.2.0:*:*:*:*:*:*:*
AI-suggested
Until a fix is available, restrict access to the Datasource REST component to trusted users and monitor for suspicious activity involving file deletions.
Description
IBM Guardium Data Protection version 12.2 contains a path traversal vulnerability in its Datasource REST component. This flaw allows an authenticated remote attacker to delete arbitrary files, potentially causing denial of service or affecting system integrity. The vulnerability is identified as CWE-22 and has a high severity rating with a CVSS score of 8.1.